Challenging the status quo is never easy. Neither is being the underdog. Startups face both of these challenges when trying to break into existing industries dominated by well-established players. Differences in the size, speed, processes, and culture of a company make it challenging for all startups to compete, regardless of the industry. For newcomers or smaller startups in their respective industries, this competition may seem daunting and the road to funding difficult, but this
Read More
PharmStars Launches Pharma-Focused Accelerator for Digital Health Startups
What You Should Know: PharmStars today announced the launch of its global digital health accelerator to transform how pharma and startups do business. PharmStars is the first and only non-proprietary accelerator for digital health startups that wish to improve their ability to engage with pharma as clients and partners. For its pharma members, PharmStars offers premium access to a curated group of the most promising digital health startups that align with their digital health strategy. The
Read More
How a Virtual Care Mindset Leads to Greater Patient Acceptance and Sustainable Telehealth Growth
There's no question that the demand for telehealth and virtual care has grown exponentially over the last twelve months. With that growth has come a fundamental shift in the attitude toward virtual care. No longer do patients and providers take a "let's try it" approach—now, it's "we must do it." This is evidenced by the number of telehealth claims filed. In 2020, telehealth claims skyrocketed, increasing by 2,938% in November 2020 versus November 2019 as patients demanded virtual options and as
Read More
Biospecimen Procurement for R&D Needs to Look More Like an Online Marketplace
As healthcare digitizes everything from insurance claims to clinical decisions, some functions remain frustratingly analog, old school, and inefficient. One such function is the distribution of human biospecimens necessary for medical research. Specimens are essential in providing much of the data that researchers examine, EHRs capture, and scientific databases aggregate. Unfortunately, the distribution of specimens and their data to researchers is woefully outdated and inefficient. Frankly,
Read More
Next-Generation Cloud Storage: Enabling Collaboration & Analytics for Pharma Research
Pharmaceutical companies today are distributed, global organizations, with research centers, manufacturing facilities, and regulatory management hubs spread all over the globe. To develop new treatments and bring them to market, all of these different functions need to collaborate more closely than ever. Using traditional, on-premises storage technologies, however, makes it difficult to share data quickly and securely, especially given that the research and manufacturing process can generate
Read More
Sharecare Acquires AI-Enabled Digital Transformation Platform doc.ai
What You Should Know: - Sharecare acquires doc.ai to expand its engineering expertise, accelerate digital transformation of healthcare through innovative AI platform for an undisclosed sum. - Founded in 2016, the company licenses AI modules and creates products for a portfolio of clients, including payers, pharma and providers. - As part of the acquisition, Anthem will now become a strategic partner with Sharecare. Sharecare, the digital health company that helps people manage all
Read More
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More
Why Some COVID-19 Testing Protocols Aren’t What You Think
While countries around the world continue to flounder with regards to COVID-19 testing, everyone is wondering how national governments could get things so horribly wrong. It’s true that governments have acted incompetently, leaders can make poor judgment calls, and optimistic testing targets are rarely achieved. But the claims of various ambitious big pharma companies—about their ability to deliver on capacity and accuracy alike—have created a smokescreen for decision-makers, one that has
Read More
H1 Secures $58M to Expand Global Healthcare Data Platform
What You Should Know: - H1, the largest database of information on every doctor
in the world raises $58M in Series B funding, just six months after raising its
Series A round during the pandemic. - H1 is the largest database in the world connecting that
provides comprehensive in-depth profiles of more than 9 million healthcare
professionals and 16,000 institutions in 70-plus countries, all of which are
kept up-to-date weekly. H1, a global
platform for the healthcare
Read More
7 Best Practices for Third-Party Risk Management in the Pharmaceutical Industry
The globalization of the pharmaceutical industry has forced pharma companies to outsource, increasing their reliance on third-party vendors and suppliers. As this supply chain grows in complexity, companies find themselves grappling with a growing amount of cyber risk. A data breach in the pharmaceutical industry can cost companies upwards of $5 million and costs can rise significantly if a third-party vendor or supplier is the cause of a data breach. For this reason, organizations must
Read More
